《半日总结》恒指跌433点 手机设备股弱 平安好医生挫9%
美国国会通过《香港人权与民主法案》，报道指中美年内或难以敲定首阶段贸易协议，港股早市造淡。恒指今早低开302点见26,587点，但已为半日高位，其後跌幅曾扩大至583点见26,306点。其後报道指国务院副总理刘鹤对贸易谈判仍审慎乐观，大市跌幅稍为收窄。恒指半日跌433点或1.6%，收26,456点；国指跌160点或1.5%，报10,458点。大市半日成交总额431.89亿元。沪、深港通南向交易半日净流入金额分别为17.32亿及6.57亿元人民币。
蓝筹股腾讯(00700.HK)跌1.8%报329.4元，友邦(01299.HK)跌1.7%报76.45元，汇控(00005.HK)跌0.9%报58元，港交所(00388.HK)跌1.3%报246元，长和(00001.HK)跌2.2%报71.3元。创科(00669.HK)及申洲(02313.HK)亦各跌1.7%。内地猪肉价格回落，万洲(00288.HK)跌4%。中资电讯股方面，中移动(00941.HK)及联通(00762.HK)均跌1.9%。
地产股向下，九仓置业(01997.HK)跌4.1%，为跌幅最大蓝筹。领展(00823.HK)、信置(00083.HK)及长实集团(01113.HK)各跌1.9%至2.2%。本地银行股中银香港(02388.HK)跌1.1%，恒生(00011.HK)及东亚(00023.HK)均跌1.5%。濠赌股跌幅较大，银娱(00027.HK)及金沙中国(01928.HK)各跌2.1%，新濠国际(00200.HK)跌2.3%，澳博(00880.HK)、永利澳门(01128.HK)及美高梅中国(02282.HK)各跌3.5%至3.8%。
内银内险股方面，建行(00939.HK)、工行(01398.HK)及中行(03988.HK)各跌1.5%至1.7%，中国平安(02318.HK)及国寿(02628.HK)各跌1.1%及3.1%。医药股走弱，石药(01093.HK)及中生制药(01177.HK)各跌3.2%及2.9%，绿叶制药(02186.HK)及复星医药(02196.HK)各跌2%及1.9%。
科网股方面，平安好医生(01833.HK)主要股东折让逾6%沽售股份，套现11亿元。该股半日跌9.4%报53.25元。美团(03690.HK)将於今日公布业绩，股价跌4.5%报92.9元。众安在线(06060.HK)跌3.5%。
手机零件股普遍受压。瑞声(02018.HK)跌2.1%，舜宇(02382.HK)及丘钛(01478.HK)各跌4%及4.3%，信利(00732.HK)发盈喜股价逆市升6.9%。晶片股华虹半导体(01347.HK)及晶片设备股ASM太平洋(00522.HK)股价均跌逾3%。
MSCI宣布暂停将雅高(03313.HK)纳入指数，该股早市暴泻近98%後停牌，停牌前报0.305元，成交近5.7亿元。卡森国际(00496.HK)遭杀人鲸资本发沽空报告狙击，股价挫90%後停牌，停牌前报0.455元，成交近8,300万元。
新股方面，澳门装修承包商华记环球(02296.HK)半日收0.295元，较上市价0.25元高18%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
